- $38.15m
- $33.47m
- $18.79m
Brief: Nephros Announces Preliminary Financial Results For Second Quarter 2020
Brief: Nephros Set To Join Russell Microcap Index
Brief: Nephros Posts Q1 Loss Per Share Of $0.13
Brief: Nephros Inc Files For Sale Of Up To 3.5 Mln Shares Of Common Stock By Selling Stockholders
Brief: Daron Evans Reports 5.1% Stake In Nephros
Brief: Nephros Announces Preliminary Financial Results For Q1 2020
Brief: Nephros Inc Establishes 2020 Revenue Guidance At $14.5 Mln To $15.5 Mln
Nephros Inc: Falls on discounted stock offering
Brief: Nephros Announces Pricing Of $7.5 Mln Underwritten Offering Of Common Stock
Brief: Nephros Announces Launch Of Plurapath, A Real-Time, Portable, Water Pathogen Detection System
Brief: Nephros Announces Preliminary Q4 Results
Brief: Nephros Inc Files For Mixed Shelf Of Up To $50 Million – SEC Filing
Brief: Nephros Qtrly Loss Per Share $0.10
U.S. STOCKS ON THE MOVE-FuelCell Energy, International Seaways, Harley-Davidson
Nephros Inc: Rises after co raises full-year rev forecast
Brief: Nephros Increases Full-Year Revenue Guidance To $9.5 Mln-10 Mln
Brief: Nephros Inc Announces Listing On Nasdaq Capital Market
Brief: Nephros Qtrly Loss Per Share $0.02
Brief: Nephros Appoints Tom Gwydir To Its Board Of Directors